NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Nanobiotix S.A (NASDAQ: NBTX)
NBTX Technical Analysis
4
As on 9th Jun 2023 NBTX STOCK Price closed @ 5.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.52 & Strong Sell for SHORT-TERM with Stoploss of 8.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NBTXSTOCK Price
Open | 5.12 | Change | Price | % |
High | 5.14 | 1 Day | -0.08 | -1.57 |
Low | 4.98 | 1 Week | 0.36 | 7.73 |
Close | 5.02 | 1 Month | 2.48 | 97.64 |
Volume | 5415 | 1 Year | -2.77 | -35.56 |
52 Week High 9.85 | 52 Week Low 1.98 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
NBTX Daily Charts |
NBTX Intraday Charts |
Whats New @ Bazaartrend |
NBTX Free Analysis |
|
NBTX Important Levels Intraday
RESISTANCE | 5.33 |
RESISTANCE | 5.23 |
RESISTANCE | 5.17 |
RESISTANCE | 5.11 |
SUPPORT | 4.93 |
SUPPORT | 4.87 |
SUPPORT | 4.81 |
SUPPORT | 4.71 |
NBTX Forecast April 2024
4th UP Forecast | 10.61 |
3rd UP Forecast | 8.82 |
2nd UP Forecast | 7.71 |
1st UP Forecast | 6.6 |
1st DOWN Forecast | 3.44 |
2nd DOWN Forecast | 2.33 |
3rd DOWN Forecast | 1.22 |
4th DOWN Forecast | -0.57 |
NBTX Weekly Forecast
4th UP Forecast | 6.10 |
3rd UP Forecast | 5.75 |
2nd UP Forecast | 5.54 |
1st UP Forecast | 5.33 |
1st DOWN Forecast | 4.71 |
2nd DOWN Forecast | 4.50 |
3rd DOWN Forecast | 4.29 |
4th DOWN Forecast | 3.94 |
NBTX Forecast2024
4th UP Forecast | 21.73 |
3rd UP Forecast | 16.37 |
2nd UP Forecast | 13.06 |
1st UP Forecast | 9.75 |
1st DOWN Forecast | 0.29 |
2nd DOWN Forecast | -3.02 |
3rd DOWN Forecast | -6.33 |
4th DOWN Forecast | -11.69 |
Nanobiotix S.A ( NASDAQ USA Symbol : NBTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NBTX Other Details
Segment | EQ | |
Market Capital | 365428160.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
NBTX Address
NBTX Latest News
NBTX Business Profile
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. The company develops NanoXray products to help patients receiving radiotherapy by enhancing the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a sterile aqueous suspension of functionalized crystalline hafnium oxide nanoparticles used for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service